Where does EndoChoice, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), EndoChoice, Inc. ranks #3,076 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does EndoChoice, Inc. hold?

EndoChoice, Inc. holds 123 US utility patents granted between 2015 and 2025, spanning 17 technology areas.

What is EndoChoice, Inc.'s Innovation Score?

EndoChoice, Inc. has an Innovation Score of 46.2 out of 100 (top 21% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does EndoChoice, Inc. focus on?

EndoChoice, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 121 patents. Grants appear in 17 CPC subclasses total.

Is EndoChoice, Inc.'s patent grant rate increasing or decreasing?

EndoChoice, Inc.'s recent grant velocity is +16% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for EndoChoice, Inc.'s patents?

EndoChoice, Inc.'s patents average 16.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the EndoChoice, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

EndoChoice, Inc.

USPTO PatentsView assignee record - 123 granted patents across 17 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Endochoice ranks #3,076 of 49,997 tracked US assignees by granted-patent volume, with 123 patents across 17 technology areas.

#3,076
of 49,997 US assignees by volume: Top 21%
by Innovation Score (46.2/100): 16.5
avg claims per patent: +16%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3076 · US Corporation #3,076 · 123 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 123 grants
TOP-DECILE #3,076/49,997
PHOTO-FINISH Abbott Medical Optics
CPC-FOCUS A61B · 17 areas
INNOV-PAR 46.2/100
CLAIMS-RICH 16.5 claims/avg
TYPE-USCORP US Corporation
VEL-UP +16% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Abbott Medical Optics Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
EndoChoice · this assignee

46
Evatec · near

46
Fieldpiece Instruments · near

46
Fingerprint Cards AB · near

46
Morpho · near

46
3D Lighting… · lowest

7

What this shows Endochoice's Innovation Score is 46.2/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Endochoice's grants concentrate

EndoChoice, Inc. is a focused PatentsView assignee: 17 CPC subclasses with 98.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (15 grants) versus a trough of 3 in 2015. By volume, Endochoice sits between Oceaneering International, Inc. and Headwater Research LLC.

Endochoice's three-year grant acceleration

From 2019–2021 to 2022–2024, EndoChoice, Inc. moved from 42 to 32 grants (0.76x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,951. See the growth leaderboard.

Oceaneering Inter…

124
Trudell Medical I…

124
Abbott Medical Op…

123
Endress+Hauser +KG

123
Everi Games

123
Futaba Industrial

123
Festo SE & KG

123
Headwater Research

123
Endochoice ◀

123

What this shows EndoChoice holds 123 patents at rank #3,077, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near EndoChoice

By rank, the assignees closest to #3,077 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in EndoChoice's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for EndoChoice, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (46 here).

Morpho, Inc. 46 Fingerprint Cards AB 46 Evatec AG 46 Fieldpiece Instruments, Inc. 46

Similar claim depth

Nearest assignees by average claims per patent (16.5 here).

Oberthur Technologies 16.5 avg Ledvance GMBH 16.5 avg Intermolecular, Inc. 16.5 avg Heatcraft Refrigeration Products LLC 16.5 avg

Endochoice's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 21% higher than 79% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

EndoChoice, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	2.4%
2016	5	4.1%
2017	13	10.6%
2018	15	12.2%
2019	15	12.2%
2020	13	10.6%
2021	14	11.4%
2022	13	10.6%
2023	8	6.5%
2024	11	8.9%
2025partial year	13	10.6%

Which technologies does EndoChoice, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 121

G02B - Optical Elements, Systems OR Apparatus 46

H04N - Pictorial Communication, e.g. Television 31

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 9

G06T - Image Data Processing OR Generation, IN General 5

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 3

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 2

F16M - Frames, Casings OR Beds OF Engines, Machines OR Apparatus, NOT Specific TO Engines, Machines OR Apparatus Provided FOR ELSEWHERE; STANDS; Supports 2

Y10T - Technical Subjects Covered BY Former US Classification 2

G05D - Systems FOR Controlling OR Regulating Non-electric Variables 2

B65G - Transport OR Storage Devices, e.g. Conveyors FOR Loading OR Tipping, Shop Conveyor Systems OR Pneumatic Tube Conveyors 2

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 2

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 15 of 17 technology areas

Where it ranks

Overall rank by patents

#3,076

of 49,997 tracked assignees

Innovation Score

46.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

EndoChoice, Inc.'s patent record in context - here's where to go next.

EndoChoice, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 98.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #3,076 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare EndoChoice, Inc. against Oceaneering International, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.